MLHFQ scores of the four commonly prescribed therapeutic regimens
| Regimen | Mean MLHFQ total score ±SD | Minimum – Maximum range |
|---|---|---|
| Conventional Triple regimen | 68.1 ± 19.8 | 26–98 |
| ARNi-based triple regimen | 57.3 ± 19.9 | 7–87 |
| SGLT2i-based triple regimen | 56.9 ± 22.2 | 21–92 |
| Quadruple regimen (GDMT) | 42.8 ± 19.0 | 9–92 |
| Regimen | Mean MLHFQ total score ±SD | Minimum – Maximum range |
|---|---|---|
| Conventional Triple regimen | 68.1 ± 19.8 | 26–98 |
| ARNi-based triple regimen | 57.3 ± 19.9 | 7–87 |
| SGLT2i-based triple regimen | 56.9 ± 22.2 | 21–92 |
| Quadruple regimen (GDMT) | 42.8 ± 19.0 | 9–92 |
Note(s): ARNi: Angiotensin Receptor-Neprilysin Inhibitor; GDMT: guideline-directed medical therapy; SD: standard deviation; SGLT-2i: sodium-glucose cotransporter 2 inhibitors